353 related articles for article (PubMed ID: 35710426)
1. Ultrasound-assisted brain delivery of nanomedicines for brain tumor therapy: advance and prospect.
Zhang S; Zhang S; Luo S; Tang P; Wan M; Wu D; Gao W
J Nanobiotechnology; 2022 Jun; 20(1):287. PubMed ID: 35710426
[TBL] [Abstract][Full Text] [Related]
2. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in nanomedicines for imaging and therapy of brain tumors.
Hasan I; Roy S; Guo B; Du S; Tao W; Chang C
Biomater Sci; 2023 Feb; 11(4):1270-1310. PubMed ID: 36648496
[TBL] [Abstract][Full Text] [Related]
4. Effect of high intensity focused ultrasound (HIFU) in conjunction with a nanomedicines-microbubble complex for enhanced drug delivery.
Han H; Lee H; Kim K; Kim H
J Control Release; 2017 Nov; 266():75-86. PubMed ID: 28928042
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-mediated blood-brain barrier opening: An effective drug delivery system for theranostics of brain diseases.
Wang J; Li Z; Pan M; Fiaz M; Hao Y; Yan Y; Sun L; Yan F
Adv Drug Deliv Rev; 2022 Nov; 190():114539. PubMed ID: 36116720
[TBL] [Abstract][Full Text] [Related]
6. Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood-brain barrier opening and brain-tumor drug delivery.
Fan CH; Ting CY; Chang YC; Wei KC; Liu HL; Yeh CK
Acta Biomater; 2015 Mar; 15():89-101. PubMed ID: 25575854
[TBL] [Abstract][Full Text] [Related]
7. Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor.
Liu HJ; Xu P
Adv Drug Deliv Rev; 2022 Dec; 191():114619. PubMed ID: 36372301
[TBL] [Abstract][Full Text] [Related]
8. Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation.
May JN; Golombek SK; Baues M; Dasgupta A; Drude N; Rix A; Rommel D; von Stillfried S; Appold L; Pola R; Pechar M; van Bloois L; Storm G; Kuehne AJC; Gremse F; Theek B; Kiessling F; Lammers T
Theranostics; 2020; 10(4):1948-1959. PubMed ID: 32042346
[No Abstract] [Full Text] [Related]
9. Focused Ultrasound-Mediated Blood-Brain Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma Treatment.
Wei HJ; Upadhyayula PS; Pouliopoulos AN; Englander ZK; Zhang X; Jan CI; Guo J; Mela A; Zhang Z; Wang TJC; Bruce JN; Canoll PD; Feldstein NA; Zacharoulis S; Konofagou EE; Wu CC
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):539-550. PubMed ID: 33346092
[TBL] [Abstract][Full Text] [Related]
10. Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy.
van den Broek SL; Shalgunov V; Herth MM
Biomater Adv; 2022 Oct; 141():213125. PubMed ID: 36182833
[TBL] [Abstract][Full Text] [Related]
11. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
12. Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer's disease.
Liu Y; Gong Y; Xie W; Huang A; Yuan X; Zhou H; Zhu X; Chen X; Liu J; Liu J; Qin X
Nanoscale; 2020 Mar; 12(11):6498-6511. PubMed ID: 32154811
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier.
Omidi Y; Kianinejad N; Kwon Y; Omidian H
Expert Rev Clin Pharmacol; 2021 Mar; 14(3):357-381. PubMed ID: 33554678
[No Abstract] [Full Text] [Related]
14. Ultrasound, microbubbles and the blood-brain barrier.
Meairs S; Alonso A
Prog Biophys Mol Biol; 2007; 93(1-3):354-62. PubMed ID: 16959303
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound and microbubbles to beat barriers in tumors: Improving delivery of nanomedicine.
Snipstad S; Vikedal K; Maardalen M; Kurbatskaya A; Sulheim E; Davies CL
Adv Drug Deliv Rev; 2021 Oct; 177():113847. PubMed ID: 34182018
[TBL] [Abstract][Full Text] [Related]
16. Emerging Anesthetic Nanomedicines: Current State and Challenges.
Zhang S; Wang Y; Zhang S; Huang C; Ding Q; Xia J; Wu D; Gao W
Int J Nanomedicine; 2023; 18():3913-3935. PubMed ID: 37489141
[TBL] [Abstract][Full Text] [Related]
17. Covalent nano delivery systems for selective imaging and treatment of brain tumors.
Ljubimova JY; Sun T; Mashouf L; Ljubimov AV; Israel LL; Ljubimov VA; Falahatian V; Holler E
Adv Drug Deliv Rev; 2017 Apr; 113():177-200. PubMed ID: 28606739
[TBL] [Abstract][Full Text] [Related]
18. Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.
Chen CC; Sheeran PS; Wu SY; Olumolade OO; Dayton PA; Konofagou EE
J Control Release; 2013 Dec; 172(3):795-804. PubMed ID: 24096019
[TBL] [Abstract][Full Text] [Related]
19. Translational strategies and systems biology insights for blood-brain barrier opening and delivery in brain tumors and Alzheimer's disease.
Song G; Plumlee P; Ahn JY; Wong ST; Zhao H
Biomed Pharmacother; 2023 Nov; 167():115450. PubMed ID: 37703663
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
